Jeffrey Guss, MD
Abstract: In 2008, the NYU Psilocybin Cancer Anxiety Research Project began seeing individuals in a controlled trial of psilocybin-assisted therapy for existential anxiety due to cancer diagnosis. At the same time, we began a training program for study therapists. In this talk, Dr. Guss, the Director of Psychedelic Therapy training, will present the training program in detail, including the therapist dyad preparations sessions, didactic approaches, mentorship, and group process work evoking spiritual states through intentional methods. Adaptation to an academic context for psychedelic healing sessions will be discussed, as well as questions of adaptation to traditional methods of training in psychiatric settings. The need to define a template for training future clinicians to use psychedelic medicines will be explored, with the complex questions of therapist selection, supervision, and potential models for clinical practice.
Jeffrey Guss, MD is a Clinical Assistant Professor of Psychiatry at the New York University School of Medicine. He is Co-Principal Investigator and Director of Psychedelic Psychotherapy for the NYU Psilocybin Cancer Anxiety Research Project. He has recently published on the topics of gender and sexuality in Psychoanalysis, Culture and Society and Studies in Gender and Sexuality. Dr. Guss maintains a private practice of psychiatry in New York City, specializing in psychotherapy as well as the outpatient treatment of addictive disorders.
|Also available on||Help translate and caption videos on|